Trademark search for:

XURVIEV

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2018-10-20 — Application filed
2018-12-13 — Sn assigned for sect 66a subseq desig from ib
2018-12-15 — Application filed
2018-12-20 — Application filed
2018-12-25 — Application filed
2019-01-03 — Assigned to examiner
2019-01-07 — Approved for pub - principal register
2019-01-30 — Notice of publication
2019-02-06 — Notice of start of opposition period created, to be sent to ib
2019-02-06 — Notification of possible opposition sent to ib
2019-02-19 — Published for opposition
2019-04-26 — Notification processed by ib
2019-05-07 — Registered-principal register
2019-06-06 — Grant of protection created, to be sent to ib
2019-06-27 — Final disposition recorded
2019-06-27 — Final disposition recorded
2019-08-23 — Notification processed by ib
2024-11-11 — Final status recorded
2025-06-09 — Death of international registration

Owner Information

NOVARTIS AG
CH

Correspondent

Novartis Pharma AG, Trademark Department
Postfach
CH-4002 Basel,
SWITZERLAND

Filing Details

Filing Date:
2018-10-20

Status Date:
2024-11-11

Category:
Pharmaceuticals

Filing Year:
2014

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.